Concepedia

Shinji Ohie

SO

Statistics

Publications

6

Citations

134

H-Index

6

Active since

1999

Affiliations

Taiho Pharmaceutical (Japan)(Current)

Keio University

Fujita Health University

Shinji Ohie is an author at Taiho Pharmaceutical (Japan) specializing in cancer pharmacology, medicine, and oncology.

Publications per year

1999–2006

6

Publications

6

Cisplatin sensitivity of ovarian cancer in the histoculture drug response assay correlates to clinical response to combination chemotherapy with cisplatin, doxorubicin and cyclophosphamide.

Shinji Ohie, Yasuhiro Udagawa, Akiko Kozu et al. · PubMed · 2000 · 34 citations

Medicine, Oncology, Pharmacology +14

Chemosensitivity testing of ovarian cancer using the histoculture drug response assay: sensitivity to cisplatin and clinical response

Shin-ichi Nakada, Daisuke Aoki, Shinji Ohie et al. · International Journal of Gynecological Cancer · 2005 · 27 citations

Medicine, Gynecology, Oncology +11

Histoculture Drug Response Assay to Monitor Chemoresponse

Shinji Ohie, Yasuhiro Udagawa, Daisuke Aoki et al. · Humana Press eBooks · 2005 · 20 citations

Medicine, Oncology, Pharmacology +13

4-[3,5-bis(trimethylsilyl)benzamido] Benzoic Acid Inhibits Angiogenesis in Colon Cancer Through Reduced Expression of Vascular Endothelial Growth Factor

Noritaka Minagawa, Yosuke Nakayama, Yuzuru Inoue et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2004 · 19 citations · Full text

Medicine, Oncology, Pharmacology +16

Antitumor Enediyne Chromoprotein C-1027: Mechanistic Investigation of the Chromophore-Mediated Self-Decomposition Pathway

Masayuki Inoue, Toyonobu Usuki, Nayoung Lee et al. · Journal of the American Chemical Society · 2006 · 18 citations

Pharmacy, Medicinal Chemistry, Molecular Biology +13

1–5 of 6